Overview

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Status:
Completed
Trial end date:
1999-01-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: Evaluate the safety and efficacy of long term recombinant human insulin-like growth factor I in children with hyperinsulinism.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Treatments:
Complement Factor I
Insulin
Mitogens